AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 161 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $254,000 | -86.7% | 8,986 | -84.5% | 0.03% | -85.8% |
| Q4 2021 | $1,908,000 | +210.7% | 58,059 | +230.8% | 0.24% | +135.3% |
| Q3 2020 | $614,000 | +61.2% | 17,552 | +49.2% | 0.10% | +96.2% |
| Q3 2019 | $381,000 | +1.6% | 11,764 | +56.3% | 0.05% | +23.8% |
| Q2 2019 | $375,000 | +43.1% | 7,528 | +121.4% | 0.04% | +200.0% |
| Q3 2018 | $262,000 | +18.6% | 3,400 | +8.5% | 0.01% | +27.3% |
| Q3 2015 | $221,000 | -81.5% | 3,134 | -70.8% | 0.01% | -76.1% |
| Q2 2015 | $1,193,000 | -59.7% | 10,734 | -65.8% | 0.05% | -61.0% |
| Q1 2015 | $2,958,000 | – | 31,367 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |